KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Capital Expenditures (2016 - 2026)

Pfizer has reported Capital Expenditures over the past 18 years, most recently at $436.0 million for Q1 2026.

  • Quarterly Capital Expenditures fell 22.7% to $436.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.5 billion through Mar 2026, down 35.82% year-over-year, with the annual reading at $2.6 billion for FY2025, 9.63% down from the prior year.
  • Capital Expenditures was $436.0 million for Q1 2026 at Pfizer, down from $845.0 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $2.2 billion in Q4 2022 and troughed at $436.0 million in Q1 2026.
  • The 5-year median for Capital Expenditures is $751.0 million (2022), against an average of $928.9 million.
  • Year-over-year, Capital Expenditures soared 145.93% in 2024 and then crashed 69.78% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $2.2 billion in 2022, then crashed by 53.29% to $1.0 billion in 2023, then surged by 90.8% to $2.0 billion in 2024, then plummeted by 57.58% to $845.0 million in 2025, then plummeted by 48.4% to $436.0 million in 2026.
  • Per Business Quant, the three most recent readings for PFE's Capital Expenditures are $436.0 million (Q1 2026), $845.0 million (Q4 2025), and $602.0 million (Q3 2025).